US FDA News: FDA Approves First Treatment for Molybdenum Cofactor Deficiency Type A

FDA approves treatment for Molybdenum Cofactor Deficiency Type A, a rare metabolic disorder characterized by severe and rapidly progressive neurologic damage.
Read more: FDA Approves First Treatment for Molybdenum Cofactor Deficiency Type A